127 related articles for article (PubMed ID: 23902552)
1. A retrospective survey of the quality of reports and their correlates among randomized controlled trials of immunotherapy for Guillain-Barré syndrome.
Lu L; Luo G; Xiao F
Immunotherapy; 2013 Aug; 5(8):829-36. PubMed ID: 23902552
[TBL] [Abstract][Full Text] [Related]
2. Quality of reporting and its correlates among randomized controlled trials on acupuncture for cancer pain: application of the CONSORT 2010 Statement and STRICTA.
Lu L; Liao M; Zeng J; He J
Expert Rev Anticancer Ther; 2013 Apr; 13(4):489-98. PubMed ID: 23560843
[TBL] [Abstract][Full Text] [Related]
3. Quality of randomized controlled trials reporting in the treatment of melasma conducted in China.
Chen Z; Chen Y; Zeng J; Wang Y; Ye T; Zhou Q; Du X; Su W; Ding Z
Trials; 2015 Apr; 16():156. PubMed ID: 25872530
[TBL] [Abstract][Full Text] [Related]
4. Assessing the quality of reports about randomized controlled trials of scalp acupuncture combined with another treatment for stroke.
You YN; Cho MR; Kim JH; Park JH; Park GC; Song MY; Choi JB; Han JY
BMC Complement Altern Med; 2017 Sep; 17(1):452. PubMed ID: 28877716
[TBL] [Abstract][Full Text] [Related]
5. Quality of reporting on randomized controlled trials on recurrent spontaneous abortion in China.
Gao J; Deng G; Hu Y; Huang Y; Lu L; Huang D; Li Y; Zhu L; Liu X; Jin X; Luo S
Trials; 2015 Apr; 16():172. PubMed ID: 25896786
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of Guillain-Barré Syndrome].
Nomura K
Brain Nerve; 2015 Nov; 67(11):1397-410. PubMed ID: 26560955
[TBL] [Abstract][Full Text] [Related]
7. Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Hughes RA; Wijdicks EF; Barohn R; Benson E; Cornblath DR; Hahn AF; Meythaler JM; Miller RG; Sladky JT; Stevens JC;
Neurology; 2003 Sep; 61(6):736-40. PubMed ID: 14504313
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for Guillain-Barré syndrome in the US hospitals.
Alshekhlee A; Hussain Z; Sultan B; Katirji B
J Clin Neuromuscul Dis; 2008 Sep; 10(1):4-10. PubMed ID: 18772694
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the quality of reporting of randomized controlled trials in acute and chronic myeloid leukemia, and myelodysplastic syndromes as governed by the CONSORT statement.
Ziogas DC; Zintzaras E
Ann Epidemiol; 2009 Jul; 19(7):494-500. PubMed ID: 19523596
[TBL] [Abstract][Full Text] [Related]
10. The role of immunotherapy in Guillain-Barré syndrome: understanding the mechanism of action.
Shahrizaila N; Yuki N
Expert Opin Pharmacother; 2011 Jul; 12(10):1551-60. PubMed ID: 21473704
[TBL] [Abstract][Full Text] [Related]
11. Guillain-Barré syndrome.
Li HF; Xie YC
Lancet Neurol; 2008 Dec; 7(12):1081-2; author reply 1083-5. PubMed ID: 19007731
[No Abstract] [Full Text] [Related]
12. Quality of reporting and fragility index for randomized controlled trials in the vesicoureteral reflux literature: where do we stand?
Gnech M; Lovatt CA; McGrath M; Rickard M; Sanger S; Lorenzo AJ; Braga LH
J Pediatr Urol; 2019 May; 15(3):204-212. PubMed ID: 31060965
[TBL] [Abstract][Full Text] [Related]
13. Quality of reports on randomized controlled trials published in Iranian journals: application of the new version of consolidated standards of reporting trials (CONSORT).
Nojomi M; Ramezani M; Ghafari-Anvar A
Arch Iran Med; 2013 Jan; 16(1):20-2. PubMed ID: 23273230
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategies in the Guillain-Barré syndrome.
Kieseier BC; Hartung HP
Semin Neurol; 2003 Jun; 23(2):159-68. PubMed ID: 12894381
[TBL] [Abstract][Full Text] [Related]
15. Quality of reporting randomized controlled trials (RCTs) in the nursing literature: application of the consolidated standards of reporting trials (CONSORT).
Smith BA; Lee HJ; Lee JH; Choi M; Jones DE; Bausell RB; Broome ME
Nurs Outlook; 2008; 56(1):31-37. PubMed ID: 18237622
[TBL] [Abstract][Full Text] [Related]
16. Quality of reporting for randomized controlled trials in the hypospadias literature: Where do we stand?
Braga LH; McGrath M; Easterbrook B; Jegatheeswaran K; Mauro L; Lorenzo AJ
J Pediatr Urol; 2017 Oct; 13(5):482.e1-482.e9. PubMed ID: 28566206
[TBL] [Abstract][Full Text] [Related]
17. [The effect of plasmapheresis and other immunomodulating therapies on the course of severe Guillain-Barré syndrome].
Hidasi E; Soltész P
Orv Hetil; 2001 Feb; 142(7):335-9. PubMed ID: 11243015
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for Guillain-Barré syndrome: a systematic review.
Hughes RA; Swan AV; Raphaël JC; Annane D; van Koningsveld R; van Doorn PA
Brain; 2007 Sep; 130(Pt 9):2245-57. PubMed ID: 17337484
[TBL] [Abstract][Full Text] [Related]
19. Assessing the quality of reports about randomized controlled trials of scalp acupuncture treatment for vascular dementia.
You YN; Cho MR; Park JH; Park GC; Song MY; Choi JB; Na CS; Han JY; Shin JC; Kim JH
Trials; 2017 May; 18(1):205. PubMed ID: 28464917
[TBL] [Abstract][Full Text] [Related]
20. Does the reporting of randomized clinical trials published in Chinese pediatrics journals improve after the CONSORT Statement is adopted?
Ma B; Ke FY; Chen ZM; Qi GQ; Li HM; Liu WJ; Zhang Y; Hu Q; Yang KH
Contemp Clin Trials; 2012 Sep; 33(5):889-94. PubMed ID: 22765929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
